Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 82
  1. Dec 19, 2025 · 16:04 · NRX

    NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis

    NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis

    01
  2. Dec 19, 2025 · 15:04 · GLAS

    Glass House applauds U.S. cannabis reform action

    Glass House applauds U.S. cannabis reform action

    02
  3. Dec 19, 2025 · 08:45 · PRN

    Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

    Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

    03
  4. Dec 19, 2025 · 08:22 · OTC

    Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital

    Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital

    04
  5. Dec 19, 2025 · 08:00 · GLAS

    Glass House Brands Applauds Cannabis Reform Action

    Glass House Brands Applauds Cannabis Reform Action

    05
  6. Dec 18, 2025 · 23:57 · AIAI

    Netramark talks Q4 contract backlog

    Netramark talks Q4 contract backlog

    06
  7. Dec 18, 2025 · 18:34 · APLI

    Appili closes $177,500 first tranche of placement

    Appili closes $177,500 first tranche of placement

    07
  8. Dec 18, 2025 · 18:33 · 4565

    Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia

    Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia

    08
  9. Dec 18, 2025 · 17:28 · BCT

    Briacell's phase 3 trial gets Nature Medicine spotlight

    Briacell's phase 3 trial gets Nature Medicine spotlight

    09
  10. Dec 18, 2025 · 17:20 · GUD

    Knight Therapeutics gets Health Canada OK for Wynzora

    Knight Therapeutics gets Health Canada OK for Wynzora

    10
  11. Dec 18, 2025 · 16:12 · THRM

    Therma Bright's InStatin targets COPD with INS-102

    Therma Bright's InStatin targets COPD with INS-102

    11
  12. Dec 18, 2025 · 16:06 · TELO

    Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program

    Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program

    12
  13. Dec 18, 2025 · 13:35 · CHS

    Comprehensive Healthcare Systems Inc. Signs a 5-Year Benefits and Pension Administration Agreement with Amalgamated Life Insurance Company, a Member of the Amalgamated Family of Companies

    Comprehensive Healthcare Systems Inc. Signs a 5-Year Benefits and Pension Administration Agreement with Amalgamated Life Insurance Company, a Member of the Amalgamated Family of Companies

    13
  14. Dec 18, 2025 · 13:00 · NURS

    Hydreight tops 1.3M orders ahead of 2025 target

    Hydreight tops 1.3M orders ahead of 2025 target

    14
← Newer Older →